Gadeta B.V.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study to Investigate the Safety and Efficacy of TEG002 in Relapsed/Refractory Multiple Myeloma Patients (NCT04688853) | Gadeta B.V. | 2021-05-13 |
Track Gadeta B.V. automatically
Every clearance here is in the API, with alerts when new ones post.